Trial Profile
Phase II trial of BP GMAX CD1 in patients with prostate cancer.
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 09 Mar 2012
Price :
$35
*
At a glance
- Drugs BPX 101 (Primary) ; Rimiducid
- Indications Prostate cancer
- Focus Therapeutic Use
- 08 Mar 2012 Planned initiation date changed from 1 Dec 2011 to 9 Sep 2011 based on information reported in a Bellicum media release.
- 21 Feb 2011 New trial record